艾曲波帕治疗异基因造血干细胞移植后难治性血小板减少的临床研究

OBJECTIVE: To evaluate the efficacy and safety of eltrombopag in post-HSCT thrombocytopenia. METHODS: A total of 10 patients who underwent post-HSCT thrombocytopenia at Peking University center, who had been treated with eltrombopag, were retrospectively evaluated. RESULTS: Of the 10 cases, 5 males...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348487/
https://www.ncbi.nlm.nih.gov/pubmed/28088971
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348487/
https://www.ncbi.nlm.nih.gov/pubmed/28088971
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.12.011

Ejemplares similares